GHRP-2 vs Sermorelin
A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
GHRP-2
GHRP-2 is a synthetic hexapeptide that acts as a ghrelin mimetic, stimulating the pituitary gland to secrete growth hormone (GH). It is one of the most potent GH secretagogues studied, producing stronger GH pulses than GHRP-6 with comparatively less appetite stimulation.
Full profileSermorelin
Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH.
Full profile| GHRP-2 | Sermorelin | |
|---|---|---|
| Category | Performance & Growth Hormone | Performance & Growth Hormone |
| Also known as | Growth Hormone Releasing Peptide-2, Pralmorelin, KP 102 | GHRH 1-29, GRF 1-29 NH2, Geref |
| Evidence | Preclinical only | FDA-approved |
| Dosing range | 100mcg–300mcg mcg, 1–3 times daily, on an empty stomach | 100mcg–500mcg mcg, once daily (before sleep) |
| Administration | Subcutaneous injection, Intramuscular injection | Subcutaneous injection |
| Key side effects | Increased hunger (less than GHRP-6), Elevated cortisol and prolactin at high doses, Water retention, Injection site irritation | Injection site redness, Headache, Flushing, Dizziness |
| Cited sources | 3 references | 1 reference |
Key differences
- Evidence level differs: GHRP-2 is preclinical only, while Sermorelin is fda-approved.
- Administration: GHRP-2 — Subcutaneous injection, Intramuscular injection; Sermorelin — Subcutaneous injection.
- Frequency: GHRP-2 is typically 1–3 times daily, on an empty stomach; Sermorelin is once daily (before sleep).
- Research depth: this profile cites 3 sources for GHRP-2 vs 1 for Sermorelin.
How each works
GHRP-2
GHRP-2 has been extensively studied in both animal and human subjects. Clinical trials have demonstrated significant GH elevation in healthy adults, with a peak GH pulse occurring 15–30 minutes post-injection. Studies show it increases IGF-1 levels with chronic use and may have mild cardioprotective properties. Unlike GHRP-6, it has a lower propensity to stimulate cortisol and prolactin at standard doses.
Sermorelin
Sermorelin works by binding pituitary GHRH receptors to stimulate GH secretion within the body's natural feedback loop. Unlike synthetic GH, it does not suppress endogenous production. Clinical studies show improved body composition, sleep quality, and IGF-1 levels in GH-deficient adults. Its short half-life (~10 min) means it requires daily dosing.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.